{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:24:58Z","timestamp":1792679098147,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002635","name":"Inha University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13770-025-00782-1","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:24:37Z","timestamp":1768375477000},"page":"343-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic Efficacy of Mesenchymal Stem Cells (MSCs) on Alzheimer\u2019s Disease: Review of Clinical Results"],"prefix":"10.1007","volume":"23","author":[{"given":"Ae-Lee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonjo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8996-8971","authenticated-orcid":false,"given":"Byung Hyune","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"782_CR1","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1186\/s12888-024-06375-x","volume":"24","author":"X Zhang","year":"2024","unstructured":"Zhang X, Guo T, Zhang Y, Jiao M, Ji L, Dong Z, et al. Global burden of Alzheimer\u2019s disease and other dementias attributed to metabolic risks from 1990 to 2021: results from the Global Burden of Disease Study 2021. BMC Psychiatry. 2024;24:910.","journal-title":"BMC Psychiatry"},{"key":"782_CR2","unstructured":"World Health Organization. Dementia. 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"key":"782_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000512","volume":"6","author":"C Reitz","year":"2020","unstructured":"Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? Neurol Genet. 2020;6:e512.","journal-title":"Neurol Genet"},{"key":"782_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101727","volume":"55","author":"M Sun","year":"2023","unstructured":"Sun M, Chen WM, Wu SY, Zhang J. Dementia risk after major elective surgery based on the route of anaesthesia: a propensity score-matched population-based cohort study. EClinicalMedicine. 2023;55:101727.","journal-title":"EClinicalMedicine"},{"key":"782_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.811852","volume":"15","author":"J Hu","year":"2022","unstructured":"Hu J, Wang X. Alzheimer\u2019s disease: from pathogenesis to mesenchymal stem cell therapy\u2013bridging the missing link. Front Cell Neurosci. 2022;15:811852.","journal-title":"Front Cell Neurosci"},{"key":"782_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.biopha.2018.06.147","volume":"106","author":"S Agatonovic-Kustrin","year":"2018","unstructured":"Agatonovic-Kustrin S, Kettle C, Morton DW. A molecular approach in drug development for Alzheimer\u2019s disease. Biomed Pharmacother. 2018;106:553\u201365.","journal-title":"Biomed Pharmacother"},{"key":"782_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20:484\u201396.","journal-title":"Lancet Neurol"},{"key":"782_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","volume":"5","author":"J Cummings","year":"2019","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2019. Alzheimer\u2019s Dementia: Transl Res Clin Interv. 2019;5:272\u201393.","journal-title":"Alzheimer's Dementia: Transl Res Clin Interv"},{"key":"782_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093272","volume":"21","author":"MT Kabir","year":"2020","unstructured":"Kabir MT, Uddin MS, Mamun AA, Jeandet P, Aleya L, Mansouri RA, et al. Combination drug therapy for the management of Alzheimer\u2019s disease. Int J Mol Sci. 2020;21:3272.","journal-title":"Int J Mol Sci"},{"key":"782_CR10","doi-asserted-by":"crossref","unstructured":"Karvelas N, Bennett S, Politis G, Kouris NI, Kole C. Advances in stem cell therapy in Alzheimer\u2019s disease: a comprehensive trial review. Stem Cell Investig. 2022;9:2.","DOI":"10.21037\/sci-2021-063"},{"key":"782_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/biomedicines11010120","volume":"11","author":"Y Duan","year":"2023","unstructured":"Duan Y, Lyu L, Zhan S. Stem cell therapy for Alzheimer\u2019s disease: a scoping review for 2017\u20132022. Biomedicines. 2023;11:120.","journal-title":"Biomedicines"},{"key":"782_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jdad1020008","volume":"1","author":"AJ Shah","year":"2024","unstructured":"Shah AJ, Dar MY, Jan B, Qadir I, Mir RH, Uppal J, et al. Neural stem cell therapy for Alzheimer\u2019s disease: a-state-of-the-art review. J Dement Alzheimer\u2019s Dis. 2024;1:19\u201325.","journal-title":"J Dement Alzheimer\u2019s Dis"},{"key":"782_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113112","volume":"324","author":"AC Boese","year":"2020","unstructured":"Boese AC, Hamblin MH, Lee JP. Neural stem cell therapy for neurovascular injury in Alzheimer\u2019s disease. Exp Neurol. 2020;324:113112.","journal-title":"Exp Neurol"},{"key":"782_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202006357","volume":"33","author":"D Huang","year":"2021","unstructured":"Huang D, Cao Y, Yang X, Liu Y, Zhang Y, Li C, et al. A nanoformulation\u2010mediated multifunctional stem cell therapy with improved beta\u2010amyloid clearance and neural regeneration for Alzheimer\u2019s disease. Adv Mater. 2021;33:2006357.","journal-title":"Adv Mater"},{"key":"782_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbrc.2020.02.074","volume":"525","author":"Y Liu","year":"2020","unstructured":"Liu Y, Huber CC, Wang H. Disrupted blood-brain barrier in 5xFAD mouse model of Alzheimer\u2019s disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes. Biochem Biophys Res Commun. 2020;525:192\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"782_CR16","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3892\/mmr.2020.10918","volume":"21","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Zhang N, Hu N, Jiang R, Lu H, Xuan A, et al. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein\/presenilin 1 transgenic mouse model of Alzheimer\u2019s disease. Mol Med Rep. 2020;21:1172\u201380.","journal-title":"Mol Med Rep"},{"key":"782_CR17","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/cells10071802","volume":"10","author":"E Armijo","year":"2021","unstructured":"Armijo E, Edwards G, Flores A, Vera J, Shahnawaz M, Moda F, et al. Induced pluripotent stem cell-derived neural precursors improve memory, synaptic and pathological abnormalities in a mouse model of Alzheimer\u2019s disease. Cells. 2021;10:1802.","journal-title":"Cells"},{"key":"782_CR18","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3389\/fimmu.2020.01781","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, Su M, Lin Y, Liu H, He Z, Lai L. Administration of amyloid precursor protein gene deleted mouse ESC-derived thymic epithelial progenitors attenuates Alzheimer\u2019s pathology. Front Immunol. 2020;11:1781.","journal-title":"Front Immunol"},{"key":"782_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4252\/wjsc.v12.i9.1032","volume":"12","author":"Y Song","year":"2020","unstructured":"Song Y, Lim JY, Lim T, Im KI, Kim NYS, et al. Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms. World J Stem Cells. 2020;12:1032\u201349.","journal-title":"World J Stem Cells"},{"key":"782_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/biom14050538","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X, Kuang Q, Xu J, Lin Q, Chi H, Yu D. MSC-based cell therapy in neurological diseases: a concise review of the literature in pre-clinical and clinical research. Biomolecules. 2024;14:538.","journal-title":"Biomolecules"},{"key":"782_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12245-025-00876-6","volume":"18","author":"O Uwishema","year":"2025","unstructured":"Uwishema O, Ghezzawi M, Wojtara M, Esene IN, Obamiro K. Stem cell therapy use in patients with dementia: a systematic review. Int J Emerg Med. 2025;18:95.","journal-title":"Int J Emerg Med"},{"key":"782_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/0004867420917467","volume":"54","author":"BN Park","year":"2020","unstructured":"Park BN, Kim JH, Lim TS, Park SH, Kim TG, Yoon BS, et al. Therapeutic effect of mesenchymal stem cells in an animal model of Alzheimer\u2019s disease evaluated by \u03b2-amyloid positron emission tomography imaging. Aust N Z J Psychiatry. 2020;54:883\u201391.","journal-title":"Aust N Z J Psychiatry"},{"key":"782_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis. 2022;13:580.","journal-title":"Cell Death Dis"},{"key":"782_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00670-x","volume":"12","author":"M Guo","year":"2020","unstructured":"Guo M, Yin Z, Chen F, Lei P. Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12:109.","journal-title":"Alzheimers Res Ther"},{"key":"782_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G, Brandi E, Vitola P, Grandi F, Ferrara G, Pischiutta F, et al. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ. 2021;28:203\u201318.","journal-title":"Cell Death Differ"},{"key":"782_CR26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.4103\/1673-5374.131596","volume":"9","author":"Y Yan","year":"2014","unstructured":"Yan Y, Ma T, Gong K, Ao Q, Zhang X, Gong Y. Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer\u2019s disease mice. Neural Regen Res. 2014;9:798\u2013805.","journal-title":"Neural Regen Res"},{"key":"782_CR27","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.2147\/JIR.S327538","volume":"14","author":"C Qin","year":"2021","unstructured":"Qin C, Li Y, Wang K. Functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer\u2019s disease: inhibition of neuroinflammation. J Inflamm Res. 2021;14:4761\u201375.","journal-title":"J Inflamm Res"},{"key":"782_CR28","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.3892\/etm.2018.6857","volume":"16","author":"Y Wei","year":"2018","unstructured":"Wei Y, Xie Z, Bi J, Zhu Z. Anti-inflammatory effects of bone marrow mesenchymal stem cells on mice with Alzheimer\u2019s disease. Exp Ther Med. 2018;16:5015\u201320.","journal-title":"Exp Ther Med"},{"key":"782_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnmol.2018.00140","volume":"11","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Chen X, Wu Y, Wang Y, Li Y, Xiang C. Transplantation of human menstrual blood-derived mesenchymal stem cells alleviates Alzheimer\u2019s disease-like pathology in APP\/PS1 transgenic mice. Front Mol Neurosci. 2018;11:140.","journal-title":"Front Mol Neurosci"},{"issue":"Suppl 1","key":"782_CR30","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3727\/096368913X672181","volume":"22","author":"T Ma","year":"2013","unstructured":"Ma T, Gong K, Ao Q, Yan Y, Song B, Huang H, et al. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer\u2019s disease mice. Cell Transplant. 2013:S113\u201326.","journal-title":"Cell Transplant"},{"key":"782_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10238-015-0375-0","volume":"16","author":"ZH Xie","year":"2016","unstructured":"Xie ZH, Liu Z, Zhang XR, Yang H, Wei LF, Wang Y, et al. Wharton\u2019s jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-beta deposition in an APP\/PS1 transgenic mouse model. Clin Exp Med. 2016;16:89\u201398.","journal-title":"Clin Exp Med"},{"key":"782_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-023-03264-0","volume":"14","author":"M Ghasemi","year":"2023","unstructured":"Ghasemi M, Roshandel E, Mohammadian M, Farhadihosseinabadi B, Akarzadehlaleh P, Shamsasenjan K. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials. Stem Cell Res Ther. 2023;14:122.","journal-title":"Stem Cell Res Ther"},{"key":"782_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s11658-022-00359-z","volume":"27","author":"M Rahbaran","year":"2022","unstructured":"Rahbaran M, Zekiy AO, Bahramali M, Jahangir M, Mardasi M, Sakhaei D, et al. Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects. Cell Mol Biol Lett. 2022;27:56.","journal-title":"Cell Mol Biol Lett"},{"key":"782_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40035-020-00199-x","volume":"9","author":"C Qin","year":"2020","unstructured":"Qin C, Lu Y, Wang K, Bai L, Shi G, Huang Y, et al. Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer\u2019s disease: a meta-analytic review on potential mechanisms. Transl Neurodegener. 2020;9:20.","journal-title":"Transl Neurodegener"},{"key":"782_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.618986","volume":"14","author":"J Steinman","year":"2021","unstructured":"Steinman J, Sun HS, Feng ZP. Microvascular alterations in Alzheimer\u2019s disease. Front Cell Neurosci. 2021;14:618986.","journal-title":"Front Cell Neurosci"},{"key":"782_CR36","unstructured":"NCT04684602. Mesenchymal stem cells for the treatment of various chronic and acute conditions. https:\/\/clinicaltrials.gov\/study\/NCT04684602"},{"key":"782_CR37","unstructured":"NCT06632470. Clinical utility and safety of human umbilical cord mesenchymal stem cell secretome in moderate neurocognitive impairment (Dementia). https:\/\/clinicaltrials.gov\/study\/NCT06632470"},{"key":"782_CR38","unstructured":"NCT04388982. The safety and the efficacy evaluation of allogenic adipose MSC-Exos in patients with Alzheimer\u2019s disease. https:\/\/clinicaltrials.gov\/study\/NCT04388982"},{"key":"782_CR39","unstructured":"NCT06607900. hUC-MSC-sEV-001 nasal drops for neurodegenerative diseases. https:\/\/clinicaltrials.gov\/study\/NCT06607900"},{"key":"782_CR40","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1007\/s11033-019-04983-5","volume":"46","author":"C Duma","year":"2019","unstructured":"Duma C, Kopyov O, Kopyov A, Berman M, Lander E, Elam M, et al. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients. Mol Biol Rep. 2019;46:5257\u201372.","journal-title":"Mol Biol Rep"},{"key":"782_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/alz.057581","volume":"17","author":"AA Oliva","year":"2021","unstructured":"Oliva AA, Brody M, Agronin M, Herskowitz B, Bookheimer SY, Hitchinson B, et al. Safety and efficacy of Lomecel-B in patients with mild Alzheimer\u2019s disease: results of a double-blinded, randomized, placebo-controlled phase 1 clinical trial. Alzheimers Dement. 2021;17:e057581.","journal-title":"Alzheimers Dement"},{"key":"782_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/alz.092295researchgate.net","volume":"20","author":"KN Ramdas","year":"2025","unstructured":"Ramdas KN, Agafonova N, Hare JM, Naioti E, Kopcho S, Cummings JL, et al. Results from a phase 2a proof-of-concept double-blind, randomized, placebo-controlled trial of Lomecel-B in mild Alzheimer\u2019s disease dementia. Alzheimers Dement. 2025;20:e092295.","journal-title":"Alzheimers Dement"},{"key":"782_CR43","unstructured":"NCT04855955. Autologous human adipose-derived mesenchymal stem cells in Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT04855955"},{"key":"782_CR44","unstructured":"NCT01297218. The safety and the efficacy evaluation of NUROSTEM-AD in patients with Alzheimer\u2019s disease. https:\/\/clinicaltrials.gov\/study\/NCT01297218"},{"key":"782_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trci.2015.06.007","volume":"1","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, et al. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase 1 clinical trial. Alzheimer\u2019s & Dementia: Transl Res Clinic Interv. 2015;1:95\u2013102.","journal-title":"Alzheimer's & Dementia: Transl Res Clinic Interv"},{"key":"782_CR46","unstructured":"NCT01696591. The long-term safety and efficacy follow-up study of subjects who completed the phase I clinical trial of Neurostem\u00ae-AD. https:\/\/clinicaltrials.gov\/study\/NCT01696591"},{"key":"782_CR47","unstructured":"NCT02054208. Safety and exploratory efficacy study of NEUROSTEM\u00ae versus placebo in patients with Alzheimer's disease."},{"key":"782_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","volume":"13","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, et al. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase I clinical trial. Alzheimers Res Ther. 2021;13:154.","journal-title":"Alzheimers Res Ther"},{"key":"782_CR49","unstructured":"NCT03172117. Follow-up study of safety and efficacy in subjects who completed NEUROSTEM\u00ae phase-I\/IIa clinical trial. https:\/\/clinicaltrials.gov\/study\/NCT03172117"},{"key":"782_CR50","unstructured":"NCT04954534. Exploratory efficacy study of NEUROSTEM\u00ae in subjects who control group of NEUROSTEM\u00ae. https:\/\/clinicaltrials.gov\/study\/NCT04954534"},{"key":"782_CR51","unstructured":"NCT03117738. A study to evaluate the safety and efficacy of AstroStem in treatment of Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT03117738"},{"key":"782_CR52","unstructured":"NCT04482413. Study to evaluate the safety and efficacy of AstroStem in treatment of Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT04482413"},{"key":"782_CR53","unstructured":"NCT04228666. A clinical trial to determine the safety and efficacy of Hope Biosciences autologous mesenchymal stem cell therapy (HB-adMSCs) for the treatment of Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT04228666"},{"key":"782_CR54","unstructured":"NCT06775964. Stem cell therapy for early Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT06775964"},{"key":"782_CR55","unstructured":"NCT01547689. Safety and efficiency of umbilical cord-derived mesenchymal stem cells (UC-MSC) in patients with Alzheimer's disease (SEMAD). https:\/\/clinicaltrials.gov\/study\/NCT01547689"},{"key":"782_CR56","unstructured":"NCT02672306. Safety and exploratory efficacy study of UCMSCs in patients With Alzheimer's disease (SEESUPAD). https:\/\/clinicaltrials.gov\/study\/NCT02672306"},{"key":"782_CR57","unstructured":"NCT04040348. Alzheimer's disease stem cells multiple infusions. https:\/\/clinicaltrials.gov\/study\/NCT04040348"},{"key":"782_CR58","unstructured":"NCT02899091. Evaluation of the safety and potential therapeutic effects of CB-AC-02 in patients With Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT02899091"},{"key":"782_CR59","unstructured":"NCT02600130. Lomecel-B infusion versus placebo in patients with Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT02600130"},{"key":"782_CR60","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/alz.12651","volume":"19","author":"M Brody","year":"2023","unstructured":"Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, et al. Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer\u2019s disease. Alzheimers Dement. 2023;19:261\u201373.","journal-title":"Alzheimers Dement"},{"key":"782_CR61","unstructured":"NCT05233774. Lomecel-B effects on Alzheimer\u2019s disease (CLEARMIND). https:\/\/www.clinicaltrials.gov\/study\/NCT05233774"},{"key":"782_CR62","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41591-025-03559-0","volume":"31","author":"BG Rash","year":"2025","unstructured":"Rash BG, Ramdas KN, Agafonova N, Naioti E, McClain-Moss L, Zainul Z, et al. Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer\u2019s disease: a randomized controlled phase 2a trial. Nat Med. 2025;31:1257\u201366.","journal-title":"Nat Med"},{"key":"782_CR63","unstructured":"NCT02833792. Allogeneic human mesenchymal stem cells for Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT02833792"},{"key":"782_CR64","unstructured":"NCT06781333. Human mesenchymal stem cells (hMSC) in behavioral problems due to Alzheimer's disease. https:\/\/clinicaltrials.gov\/study\/NCT06781333"},{"key":"782_CR65","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32:252\u201360.","journal-title":"Nat Biotechnol"},{"key":"782_CR66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","volume":"14","author":"T Zhou","year":"2021","unstructured":"Zhou T, Yuan Z, Weng J, Pei D, Du X, He C, et al. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14:24.","journal-title":"J Hematol Oncol"},{"key":"782_CR67","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4330\/wjc.v16.i12.776","volume":"16","author":"P Li","year":"2024","unstructured":"Li P. Comparative breakthrough: umbilical cord mesenchymal stem cells vs bone marrow mesenchymal stem cells in heart failure treatment. World J Cardiol. 2024;16:776\u201380.","journal-title":"World J Cardiol"},{"key":"782_CR68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1479-5876-12-8","volume":"12","author":"MS Choudhery","year":"2014","unstructured":"Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Donor age negatively impacts adipose tissue\u2013derived mesenchymal stem cell expansion and differentiation. J Transl Med. 2014;12:8.","journal-title":"J Transl Med"},{"key":"782_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.","journal-title":"Front Immunol"},{"key":"782_CR70","doi-asserted-by":"publisher","first-page":"8129","DOI":"10.7150\/thno.62069","volume":"11","author":"AS Cone","year":"2021","unstructured":"Cone AS, Yuan X, Sun L, Duke LC, Vreones MP, Carrier AN, et al. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer\u2019s disease-like phenotypes in a preclinical mouse model. Theranostics. 2021;11:8129\u201342.","journal-title":"Theranostics"},{"key":"782_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/632902","volume":"2015","author":"S Lee","year":"2015","unstructured":"Lee S, Choi E, Cha MJ, Hwang KC. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy. Oxid Med Cell Longev. 2015;2015:632902.","journal-title":"Oxid Med Cell Longev"},{"key":"782_CR72","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/wound.2022.0107","volume":"12","author":"CT Huerta","year":"2023","unstructured":"Huerta CT, Ortiz YY, Liu ZJ, Velazquez OC. Methods and limitations of augmenting mesenchymal stem cells for therapeutic applications. Adv Wound Care. 2023;12:467\u201381.","journal-title":"Adv Wound Care"},{"key":"782_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbr.2017.10.032","volume":"339","author":"X Wang","year":"2018","unstructured":"Wang X, Ma S, Yang B, Huang T, Meng N, Xu L, et al. Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer\u2019s disease. Behav Brain Res. 2018;339:297\u2013304.","journal-title":"Behav Brain Res"},{"key":"782_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113706","volume":"341","author":"AF Neves","year":"2021","unstructured":"Neves AF, Camargo C, Premer C, Hare JM, Baumel B, Pinto M. Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer\u2019s disease. Exp Neurol. 2021;341:113k706.","journal-title":"Exp Neurol"},{"key":"782_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12179","volume":"7","author":"J Cummings","year":"2021","unstructured":"Cummings J, Lee G, Zhong K, Fonseca J, Taghva K. Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimers Dement (N Y). 2021;7:e12179.","journal-title":"Alzheimers Dement (N Y)"},{"key":"782_CR76","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"782_CR77","doi-asserted-by":"crossref","unstructured":"Ito K, Corrigan B, Romero K, Anziano R, Neville J, Stephenson D, et al. Understanding placebo responses in Alzheimer's disease clinical trials from the literature meta-data and CAMD database. J Alzheimers Dis. 2013;37:173\u201383.","DOI":"10.3233\/JAD-130575"},{"key":"782_CR78","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/bs.irn.2020.03.032","volume":"153","author":"K Ito","year":"2020","unstructured":"Ito K, Romero K. Placebo effects in subjects with cognitive impairment. Int Rev Neurobiol. 2020;153:213\u201330.","journal-title":"Int Rev Neurobiol"},{"key":"782_CR79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"782_CR80","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s13770-024-00634-4","volume":"21","author":"S Che Shaffi","year":"2024","unstructured":"Che Shaffi S, Hairuddin ON, Mansor SF, Syafiq TMF, Yahaya BH. Unlocking the potential of extracellular vesicles as the next generation therapy: challenges and opportunities. Tissue Eng Regen Med. 2024;21:513\u201327.","journal-title":"Tissue Eng Regen Med"},{"key":"782_CR81","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s13770-023-00551-y","volume":"20","author":"DH Lee","year":"2023","unstructured":"Lee DH, Yun DW, Kim YH, Im GB, Hyun J, Park HS, et al. Various three-dimensional culture methods and cell types for exosome production. Tissue Eng Regen Med. 2023;20:621\u201335.","journal-title":"Tissue Eng Regen Med"},{"key":"782_CR82","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s13770-023-00557-6","volume":"20","author":"AK Zhou","year":"2023","unstructured":"Zhou AK, Jou E, Lu V, Zhang J, Chabra S, Abishek J, et al. Using pre-clinical studies to explore the potential clinical uses of exosomes secreted from induced pluripotent stem cell-derived mesenchymal stem cells. Tissue Eng Regen Med. 2023;20:793\u2013809.","journal-title":"Tissue Eng Regen Med"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-025-00782-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-025-00782-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-025-00782-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:55:32Z","timestamp":1774619732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-025-00782-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1007\/s13770-025-00782-1","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not contain any clinical trials or animal experiments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}